HomeAnnouncementsGeneral AnnouncementsFREE CE: Cancer Therapy-Related Dermatologic Toxicities

FREE CE: Cancer Therapy-Related Dermatologic Toxicities

Subject: FREE CE: Cancer Therapy-Related Dermatologic Toxicities
Posted by: (guest@readyportal.net)
Date Posted: 1/24/17
  text 
Members are invited to participate in a free CE activity titled, Update on Nursing Management of Cancer Therapy-Related Dermatologic Toxicities. Those who complete the online activity will earn 1.0 contact hour. Many patients who receive novel targeted therapies and immunotherapies develop dermatologic toxicities that are associated with impaired quality of life due to sequelae such as pain, pruritus, and anxiety. The type and severity of dermatologic toxicity can vary significantly between classes of agents and pose distinct nursing management challenges in prophylaxis, treatment, and monitoring. Despite data supporting the efficacy of novel targeted therapies and immunotherapies in various tumor types, research has shown that the physical and emotional toll of dermatologic toxicities often causes treatment interruptions or discontinuations, even when their manifestation is associated with superior response rates and survival. Patients who do not receive the recommended doses and schedules for their anticancer therapies are at risk for suboptimal outcomes. You can access the activity here: http://www.i3health.com/ce/dermatologic-toxicities If you have any questions, please do not hesitate to contact Amanda Thompson at athompson@i3health.com.